Unilever PLC
12 August 2003
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
UNILEVER PLC
2) Name of director
CLAUDIO X GONZALEZ
3) Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18 or in respect of a non-beneficial
interest
AS IN 2 ABOVE - MR GONZALEZ IS AN ADVISORY DIRECTOR
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
The shares are held in the Bank of New York's account with the Depository Trust
Company (DTC). The Bank of New York nominee name for DTC is 'Cede & Co'.
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
N/A
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
PURCHASE OF PLC AMERICAN DEPOSITARY RECEIPTS (1 ADR REPRESENTS 4 PLC ORDINARY
SHARES)*
7) Number of shares/amount of
stock acquired
5,000 ADRs
8) Percentage of issued class
NEGLIGIBLE
9) Number of shares/amount
of stock disposed
N/A
10) Percentage of issued class
N/A
11) Class of security
ORDINARY SHARES OF 1.4P EACH
12) Price per share
US $33.6000 PER ADR*
13) Date of transaction
11 AUGUST 2003
14) Date company informed
11 AUGUST 2003
15) Total holding following this notification
25,000 ADRs (REPRESENTING 100,000 PLC ORDINARY SHARES)
16) Total percentage holding of issued class following this notification
0.0034% OF THE PLC ORDINARY 1.4P CAPITAL
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
N/A
18) Period during which or date on which exercisable
N/A
19) Total amount paid (if any) for grant of the option
N/A
20) Description of shares or debentures involved: class, number
N/A
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
N/A
22) Total number of shares or debentures over which options held
following this notification
N/A
23) Any additional information
N/A
24) Name of contact and telephone number for queries
AM DEGUN 020 7822 6039
25) Name and signature of authorised company official responsible for
making this notification
ALISON DILLON
DEPUTY SECRETARY
Date of Notification
12 AUGUST 2003
This information is provided by RNS
The company news service from the London Stock Exchange A
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.